Thank you for standing by and welcome to the Corvus Pharmaceuticals fourth-quarter and full-year 2024 business update and financial results conference call. (Operator Instructions) It is now my ...

("Osaic"), one of the nation's largest providers of wealth management solutions, today announced that Ever Wealth, an Auburn, Indiana-based advisory firm with more than $170 million in client assets, ...

In a report released today, David Arcaro from Morgan Stanley maintained a Buy rating on Public Service Enterprise (PEG – Research Report), with ...

J.P. Morgan analyst Jeremy Tonet maintained a Buy rating on Public Service Enterprise (PEG – Research Report) on March 17 and set a price ...

NeueHealth Inc (NEUE) is expected to report for 4Q. NeuroMetrix Inc (NURO) is expected to report for 4Q. Nikola Corp (NKLAQ) is expected to report for 4Q. Nu Ride Inc (NRDE) is expected to report for ...

Q4 2024 Management View CEO Richard Miller detailed the progress of soquelitinib, emphasizing its potential as a first-in-class oral therapy for immune diseases and cancers. He highlighted the 39% ...

Long-term stability indicates a strong investment culture. On average, Ladenburg Thalmann's longest-tenured strategy managers have 15 years of tenure. This level of experience should give ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

RILYL B. Riley Financial, Inc.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $82.0, a high estimate of $85.00, and a low estimate of $78.00. Observing a 10.32% ...

Lument Finance Trust, Inc. ( NYSE: LFT) Q4 2024 Earnings Conference Call March 20, 2025 8:30 AM ET Andrew Tsang - Investor Relations Jim Flynn - CEO Jim Briggs - CFO Jim Henson - President Zach ...